Publications by authors named "Meryem Jefferies"

Claim this Profile
P
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study.
Annabelle Stevens, Jake Abbott, Loriate Gribbin, Sarah Ahmed, Mark Montebello, Meryem Jefferies

Int J Drug Policy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review.
Meryem Jefferies, Robert Graham, Marguerite Tracy, Scott Read, Mohammed Eslam

J Med Internet Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse.
Samuel Lawson, Jamie Bryant, Megan Freund, Joshua Dizon, Paul S Haber, Meryem Jefferies

Drug Alcohol Rev· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'It's a fragile open door'-enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder.
Bridin Murnion, Jane E Carland, Meryem Jefferies, Michael Au, Marguerite Tracy

J Public Health (Oxf)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies

Subst Abuse Treat Prev Policy· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out.
Meryem Jefferies, Harunor Rashid, Robert Graham, Scott Read, Gouri R Banik

Vaccines (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
Mark Montebello, Meryem Jefferies, Llewellyn Mills, Raimondo Bruno, Jan Copeland

Drug Alcohol Depend· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.
Rachel M Deacon, Kristie Mammen, Raimondo Bruno, Llewellyn Mills, Adrian Dunlop, Meryem Jefferies

Addiction· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brief History of Ebolavirus Disease: Paving the Way Forward by Learning from the Previous Outbreaks.
Meryem Jefferies, Harunor Rashid, Grant A Hill-Cawthorne, Veysel Kayser

Infect Disord Drug Targets· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial.
Nicholas Lintzeris, Llewellyn Mills, Adrian Dunlop, Jan Copeland, Iain Mcgregor, Meryem Jefferies

Drug Alcohol Depend· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.
Llewellyn Mills, Nicholas Lintzeris, Raimondo Bruno, Mark Montebello, Adrian Dunlop, Meryem Jefferies

Drug Alcohol Rev· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
Sahar Bajis, Jason Grebely, Behzad Hajarizadeh, Tanya Applegate, Alison D Marshall, Meryem Jefferies

J Viral Hepat· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Nicholas Lintzeris, Lauren A Monds, Maria Bravo, Phillip Read, Mary E Harrod, Meryem Jefferies

Drug Alcohol Rev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial.
Nicholas Lintzeris, Anjali Bhardwaj, Llewellyn Mills, Adrian Dunlop, Jan Copeland, Meryem Jefferies

JAMA Intern Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on global epidemiology of viral hepatitis and preventive strategies.
Meryem Jefferies, Bisma Rauff, Harunor Rashid, Thao Lam, Shafquat Rafiq

World J Clin Cases· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep.
Anita Gamvrellis, Simone Gloster, Meryem Jefferies, Patricia L Mottram, Peter Smooker

Vet Immunol Immunopathol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ion transport blockers inhibit human rhinovirus 2 release.
Elena V Gazina, David N Harrison, Meryem Jefferies, Heneu Tan, David Williams

Antiviral Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis